Telehealth-based Symptom Management for Veterans Treated With Selinexor

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Durham VA Medical Center
Study ID
NCT06452446
Status
Active Not Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Not accepted

Interventions

  • Selinexor — DRUG
    Selinexor is an oral therapy that is FDA approved for multiple myeloma and diffuse large B-cell lymphoma that have returned after prior therapy. Side effects like nausea, vomiting, and fatigue can affect how long a patient is able to continue taking Selinexor, which could mean that treatment might stop sooner.

Study Details

The purpose of this study is to find out if continued monitoring of side effects from Selinexor and prescribed medication to prevent side effects helps improve symptoms, quality of life, and ability to continue the treatment longer.

Key Dates

Start date
Sep 1, 2024
Status verified
Feb 2025
Primary completion
Jul 1, 2026
Completion
Jul 1, 2028

Study Design

Enrollment
20 participants (estimated)

Primary Outcome Measure

Primary Outcome Measure [ Time Frame: 2 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Durham VA Medical CenterDurhamNorth Carolina27705-

Find similar trials in Durham, NC

By condition
Multiple myeloma
By specialty
OncologyBlood cancer
By research site
Durham VA Medical Center· Durham, NC

Related Studies